Everolimus in CDK12-Deficient Metastatic Colorectal Cancer (EVER-RECODE)

NCT07435584 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: Everolimus (Afinitor) tablets

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University